financetom
Business
financetom
/
Business
/
CrowdStrike forecasts upbeat annual results, shares surge 25%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CrowdStrike forecasts upbeat annual results, shares surge 25%
Mar 5, 2024 3:02 PM

March 5 (Reuters) - CrowdStrike Holdings ( CRWD )

forecast annual results above Wall Street estimates on Tuesday,

lifted by strong enterprise spending on cybersecurity to counter

rising online threats, sending its shares soaring in extended

trade.

Shares of CrowdStrike ( CRWD ) jumped 25%, lifting its stock market

value by about $18 billion, while other cybersecurity stocks

also rallied. SentinelOne ( S ) jumped 6.9%, while Palo Alto

Networks ( PANW ) and Fortinet ( FTNT ) each gained over 3%, and

Zscaler ( ZS ) rose over 2%.

The fast adoption of generative AI has opened new challenges

for enterprises and has led to investments in cybersecurity

services, such as the ones offered by CrowdStrike ( CRWD ), to secure

their business operations against external threats.

Analysts expect CrowdStrike ( CRWD ), which offers unified platforms

such as Falcon, to benefit from improved spending trends.

The company sees adjusted profit between $3.77 and $3.97 per

share for fiscal 2025, above analysts' expectations of $3.75,

according to LSEG data.

The Austin, Texas-based company expects annual revenue

between $3.92 billion and $3.99 billion, the midpoint of which

was above estimates of $3.94 billion.

It expects first-quarter revenue between $902.2 million and

$905.8 million, above analysts' estimates of $899.3 million.

Excluding items, it expects profit between 89 cents and 90

cents per share in the first quarter, which was also above

expectations.

The company said it agreed to acquire cloud data runtime

security solution, Flow Security, to expand its data protection

offerings for the cloud.

Crowdstrike's ( CRWD ) revenue for the fourth quarter ended Jan. 31

rose 32.6% to $845.3 million, beating Street expectations of

$839.1 million.

"CrowdStrike's ( CRWD ) quarterly revenue signaled ongoing strong

and stable demand for offerings from the premium cybersecurity

vendor, which our experts continue to characterize as a leader

in the market," said Jordan Berger, an analyst at Third Bridge.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved